Second Leading Proxy Advisor Rejects Meir Jakobsohn’s Attempt to Take Control of Knight Therapeutics’ Board
Glass Lewis becomes second leading proxy advisory firm to recommend that Knight shareholders reject Meir Jakobsohn’s scheme to take control of Knight; notes “lingering concerns” with respect to Mr. Jakobsohn’s “motivations and behavior” Glass Lewis joins …